Skip to content
ppharmaranks
Menu
Class IOngoing

PHENYLephrine added to 0.9% sodium chloride recall

FDA recall D-0272-2025 · initiated Feb 20, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 19, 2025How we research

Central Admixture Pharmacy Services, Inc. recalled PHENYLephrine added to 0.9% sodium chloride in Feb 2025 — an FDA Class I recall (D-0272-2025) because Presence of Particulate Matter.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Presence of Particulate Matter

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot 37-928390, Exp Date, 03MAR2025; Lot 37-928796, Exp Date, 09MAR2025; Lot 37-928839, Exp Date, 10MAR2025

Quantity recalled: 1546 bags

Details

Product
PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, 855-275-2270, NDC 71285-6092-1.
Recalling company
Central Admixture Pharmacy Services, Inc.
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Product was distributed nationwide within the United States
Initiated
Feb 20, 2025
FDA report date
Mar 19, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was PHENYLephrine added to 0.9% sodium chloride recalled?
Central Admixture Pharmacy Services, Inc. recalled PHENYLephrine added to 0.9% sodium chloride in Feb 2025 — an FDA Class I recall (D-0272-2025) because Presence of Particulate Matter. Most serious — a reasonable probability that use will cause serious harm or death.
Why was PHENYLephrine added to 0.9% sodium chloride recalled?
Per the FDA enforcement record, the reason for recall D-0272-2025 was: Presence of Particulate Matter
Is a recalled PHENYLephrine added to 0.9% sodium chloride dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of PHENYLephrine added to 0.9% sodium chloride are affected?
Distributed: Product was distributed nationwide within the United States. The recall covers these lots — Lot 37-928390, Exp Date, 03MAR2025; Lot 37-928796, Exp Date, 09MAR2025; Lot 37-928839, Exp Date, 10MAR2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0272-2025.

Source: openFDA Drug Enforcement record D-0272-2025

← All drug recalls